Lexaria Bioscience Corp.

NASDAQ:LEXX

2.83 (USD) • At close October 17, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

202320222021202020192018201720162015201420132012201120102009200820072006
Omzet 0.2260.2550.7230.3850.2230.4330.0640.0410.0151.0971.3581.1340.3620.4220.9010.2530.020.02
Kosten van de omzet 0.0320.0720.1750.0990.0230.0250.030.0460.030.7950.7830.6680.2740.5480.9130.1250.0930.093
Brutowinst 0.1950.1840.5470.2850.20.4080.034-0.005-0.0150.3020.5740.4660.089-0.126-0.0120.128-0.073-0.073
Brutowinstmarge 0.8610.7190.7570.7420.8970.9420.533-0.12-1.0330.2750.4230.4110.245-0.299-0.0130.507-3.595-3.595
Onderzoek- en ontwikkelingskosten 3.6671.8431.2630.3870.5560.4930.0540.0090.146000000000
Algemene en administratieve kosten 3.0625.7254.9713.5693.1286.0241.6331.0121.4861.2730.5620.6780.4670.4580.4751.010.1210
Verkoop- en marketingkosten 0000.2040.5150.4890.2090.1850.2770.0080.0030.0410.0010.0010.0040.020.020
Verkoop-, algemene en administratieve kosten 3.0625.7254.9713.7743.6436.5131.8421.1971.7630.0080.5650.7190.4670.4590.4791.030.1420.035
Overige kosten 0000.1130.0610.002-0.0010.005-0.02300.0140.00600.0080.0010.148-0.0030
Bedrijfskosten 6.7297.5676.2344.2734.267.0081.8951.2111.9130.0080.5790.7250.4740.4670.4811.1780.1390.035
Bedrijfsresultaat -6.534-7.384-5.687-3.892-3.961-6.6-1.861-1.216-1.9280.294-0.005-0.26-0.552-0.754-0.898-1.05-0.49-0.035
Bedrijfsresultaat ratio -28.885-28.91-7.868-10.121-17.794-15.233-29.247-29.854-131.1530.268-0.004-0.229-1.524-1.786-0.997-4.148-24.113-1.73
Totaal overige inkomsten en kosten netto -0.222-0.7651.523-0.193-0.197-0.009-0.062-0.059-0.024-0.349-0.247-0.279-0-0-0.379-0.005-0.278-0.04
Inkomen voor belasting -6.713-7.384-4.164-4.085-4.158-6.609-1.929-1.277-1.983-1.871-0.252-0.538-0.552-0.754-0.971-1.055-0.212-0.076
Inkomen voor belasting ratio -29.674-28.91-5.762-10.622-18.68-15.254-30.319-31.368-134.898-1.705-0.185-0.475-1.524-1.786-1.078-4.167-10.417-3.722
Belastingkosten 0.131-0.114-1.66-0.0540.04-0.009-0.054-0.06-0.1810.2940.2470.2790.167-00.0070.0010.5750.041
Nettowinst -6.665-7.269-2.504-4.03-4.198-6.599-1.869-1.215-1.771-1.871-0.252-0.538-0.552-0.754-0.978-1.056-0.508-0.076
Nettowinstmarge -29.464-28.463-3.465-10.481-18.858-15.23-29.373-29.834-120.426-1.705-0.185-0.475-1.524-1.786-1.086-4.171-25.029-3.729
WPA (Winst Per Aandeel) -1.01-1.24-0.57-1.45-1.62-2.79-0.95-0.83-1.34-0.073-0.42-1.09-1.22-2.8-4.46-5.21-3.16-1.37
Verwaterde WPA -1.01-1.24-0.57-1.45-1.62-2.79-0.95-0.83-1.34-0.073-0.42-1.09-1.22-2.8-4.46-5.21-3.16-1.37
EBITDA -6.167-7.242-7.062-3.779-3.901-6.598-1.86-1.215-1.9510.2940.4520.111-0.263-0.2510.339-0.9020.1480.005
EBITDA ratio -27.262-28.357-9.771-9.828-17.522-15.228-29.224-29.838-132.6950.2680.3330.098-0.726-0.5960.377-3.5627.3050.261